The market for minimally invasive surgery (MIS) was estimated to be worth USD 60 billion in 2023 and is expected to increase to USD 116.92 billion by 2030, with a projected compound annual growth rate (CAGR) of 10% from 2024 to 2030.
The Minimally Invasive Surgery (MIS) market growth is fueled by the increasing preference for minimally invasive procedures due to their benefits, such as reduced pain, shorter recovery times, and minimized hospital stays. North America and Europe lead the market, thanks to advanced healthcare infrastructure and high adoption rates of MIS techniques, while the Asia-Pacific region is expected to exhibit the highest growth, driven by improving healthcare facilities and rising disposable incomes. Despite challenges like high costs and a shortage of skilled professionals, the market presents significant opportunities, particularly in emerging economies and the expanding field of robotic surgery.
Key Insights:
Global Minimally Invasive Surgery (MIS) Market Drivers:
Technological Advancements Driving the Market Growth Globally
The Minimally Invasive Surgery (MIS) market is being propelled by continuous technological advancements. Innovations such as robotic-assisted surgery, high-definition imaging, and enhanced endoscopic equipment have significantly improved the precision, safety, and effectiveness of minimally invasive procedures. These technological improvements reduce recovery times, minimize surgical risks, and enhance patient outcomes, driving greater adoption of MIS techniques across various medical specialties.
Growing Prevalence of Chronic Diseases.
As the global population ages, the incidence of these diseases rises, necessitating more surgical interventions. Minimally invasive surgeries offer a less traumatic alternative to traditional open surgeries, resulting in fewer complications, shorter hospital stays, and quicker recoveries, which makes them an attractive option for managing chronic conditions.
Patient Preference for Minimally Invasive Procedures.
Patient preference for minimally invasive procedures is another key driver of the MIS market. Patients are increasingly opting for MIS due to its numerous benefits, including reduced pain, smaller incisions, lower risk of infection, and faster recovery times. The growing awareness of these advantages, coupled with rising healthcare literacy, has led to a significant shift towards minimally invasive options, thereby boosting the demand for MIS across healthcare settings.
Global Minimally Invasive Surgery (MIS) Market Restraints and Challenges:
High Costs of Minimally Invasive Surgical Devices.
One of the significant restraints in the Minimally Invasive Surgery (MIS) market is the high cost of surgical devices and equipment. Advanced technologies like robotic-assisted systems and high-definition imaging tools require substantial investment, making them expensive for healthcare providers. This financial barrier limits the adoption of MIS techniques, particularly in smaller hospitals and clinics with constrained budgets, and in low to middle-income countries where healthcare expenditure is lower.
Lack of Skilled Professionals.
The MIS market also faces challenges due to a shortage of skilled professionals. Performing minimally invasive procedures requires specialized training and expertise, which not all surgeons possess. The learning curve associated with mastering these advanced techniques can be steep, and training programs may be insufficient or inaccessible in certain regions. This lack of skilled personnel can hinder the widespread implementation of MIS, impacting its overall market growth.
Limited Reimbursement Policies.
Another major challenge in the MIS market is the inconsistency and limitations in reimbursement policies. In many regions, insurance providers and government health programs do not fully cover the costs of minimally invasive procedures or the advanced equipment used, leading to higher out-of-pocket expenses for patients. This financial burden can deter patients from opting for MIS, thereby restricting its market penetration. To overcome this, efforts to standardize and expand reimbursement coverage are essential to making MIS more accessible and affordable.
Global Minimally Invasive Surgery (MIS) Market Opportunities:
Emerging Markets.
The Minimally Invasive Surgery (MIS) market holds substantial growth potential in emerging markets such as Asia-Pacific, Latin America, and parts of Africa. These regions are experiencing rapid economic growth, increased healthcare expenditure, and improvements in healthcare infrastructure. Companies that can navigate these markets and establish strong distribution networks are likely to capture a significant share of the growing demand for MIS.
Advancements in Robotic Surgery.
Advancements in robotic surgery present a notable opportunity for the MIS market. Robotic-assisted surgical systems offer enhanced precision, control, and flexibility, leading to better patient outcomes and reduced recovery times. The increasing adoption of these systems in hospitals and surgical centers, driven by continuous technological innovations and decreasing costs, is expected to propel the growth of the MIS market. Furthermore, ongoing research and development in this field promise to introduce more sophisticated and affordable robotic solutions, further expanding the market.
MINIMALLY INVASIVE SURGERY MARKET REPORT COVERAGE:
REPORT METRIC |
DETAILS |
Market Size Available |
2023 - 2030 |
Base Year |
2023 |
Forecast Period |
2024 - 2030 |
CAGR |
10% |
Segments Covered |
By Type of Surgery, Device Type, End-User, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
Key Companies Profiled |
Medtronic plc, Johnson & Johnson (Ethicon, Inc.), Stryker Corporation, Intuitive Surgical, Inc., Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Smith & Nephew plc, Abbott Laboratories, Karl Storz GmbH & Co. KG, Zimmer Biomet Holdings, Inc., Applied Medical Resources Corporation |
Laparoscopic Surgery
Endoscopic Surgery
Robotic Surgery
Others
Laparoscopic surgery is considered the cornerstone of minimally invasive techniques due to its widespread adoption and proven efficacy across a range of surgical applications. This type of surgery involves making small incisions through which a laparoscope—a thin tube with a camera and light—is inserted to provide a magnified view of the internal organs on a monitor. Surgeons can perform complex procedures with precision, significantly reducing the trauma associated with traditional open surgeries. Laparoscopic surgery is highly effective for procedures such as cholecystectomy, appendectomy, hernia repair, and various gynecological operations. Its benefits include shorter recovery times, reduced pain, lower risk of infection, and minimal scarring, making it a preferred choice for both patients and healthcare providers. The continuous advancements in laparoscopic instruments and techniques further enhance its effectiveness, solidifying its dominant position in the global MIS market.
Handheld Instruments
Electrosurgical Instruments
Guiding Devices
Inflation Systems
Others
Electrosurgical instruments are among the most effective device types in the Minimally Invasive Surgery (MIS) market, playing a crucial role in enhancing precision and efficiency during surgical procedures. These instruments use high-frequency electrical currents to cut, coagulate, desiccate, or fulgurate tissue, allowing for precise control over bleeding and tissue manipulation. The ability to quickly switch between cutting and coagulating modes reduces intraoperative blood loss and minimizes the need for traditional sutures and staples, thereby shortening operative times and improving patient outcomes. Electrosurgical devices, including generators and specialized instruments like electrosurgical pencils and forceps, are widely used across various types of MIS, from laparoscopic and endoscopic surgeries to more complex robotic-assisted procedures. Their effectiveness is further amplified by advancements in technology, such as the integration of feedback systems that adjust power output based on tissue resistance, ensuring consistent performance and safety. This combination of versatility, precision, and enhanced safety makes electrosurgical instruments indispensable in modern minimally invasive surgeries.
Hospitals
Ambulatory Surgical Centers (ASCs)
Clinics
Specialty Clinics
Others
Among the diverse landscape of end-users within the healthcare industry, hospitals stand out as the most effective segment for several reasons. Hospitals serve as comprehensive healthcare hubs, offering a wide range of medical services and specialties under one roof. Their ability to handle complex cases, and emergencies, and provide continuous care sets them apart. Moreover, hospitals often have the infrastructure and resources to invest in cutting-edge technology, advanced medical equipment, and specialized staff, ensuring optimal patient care. Additionally, hospitals typically have established networks and collaborations with other healthcare providers, facilitating seamless referrals and coordinated patient management. These factors collectively position hospitals as the most effective end-user segment, playing a pivotal role in delivering high-quality healthcare services to diverse patient populations.
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global market for Minimally Invasive Surgery (MIS) is characterized by varying regional shares, reflecting the unique healthcare landscapes and adoption rates across different parts of the world. North America commands the largest market share at 32%, driven by advanced healthcare infrastructure, favorable reimbursement policies, and a high prevalence of chronic diseases necessitating minimally invasive procedures. Following closely, Europe holds a significant share of 28%, buoyed by technological advancements, strong regulatory frameworks, and increasing acceptance of MIS techniques among healthcare professionals and patients alike. In the Asia-Pacific region, which accounts for 22% of the market, rapid urbanization, expanding healthcare expenditure, and growing awareness about the benefits of MIS contribute to its substantial share. South America the Middle East and Africa regions hold smaller but notable shares of 10% and 8%, respectively, with increasing investments in healthcare infrastructure and rising adoption of MIS techniques driving market growth. As healthcare systems worldwide continue to prioritize patient outcomes, cost-effectiveness, and quicker recovery times, the demand for minimally invasive surgical procedures is expected to further proliferate across these regions, shaping the future landscape of the MIS market.
COVID-19 Impact Analysis on the Global Minimally Invasive Surgery (MIS) Market:
The COVID-19 pandemic has significantly impacted the global Minimally Invasive Surgery (MIS) market, both positively and negatively. Initially, the outbreak led to disruptions in elective procedures and surgical schedules, causing a temporary decline in MIS volumes as healthcare resources were redirected towards managing the pandemic. However, as healthcare systems adapted to the new reality, there has been a notable shift towards MIS techniques due to their associated benefits, such as shorter hospital stays, reduced risk of infections, and faster recovery times. Additionally, the pandemic has accelerated the adoption of telemedicine and remote monitoring solutions, further facilitating the uptake of minimally invasive procedures. Furthermore, heightened awareness of infection control measures has emphasized the importance of minimally invasive techniques, driving demand for MIS devices and equipment. Looking ahead, as healthcare systems recover and adapt to the post-pandemic landscape, the MIS market is expected to witness sustained growth fueled by ongoing technological advancements, favorable reimbursement policies, and increasing patient preference for less invasive treatment options.
Latest Trends/ Developments:
The Minimally Invasive Surgery (MIS) market is witnessing several notable trends and developments that are reshaping the landscape of surgical procedures. One significant trend is the increasing adoption of robotic-assisted surgery, which offers enhanced precision, dexterity, and visualization, leading to improved patient outcomes. Advancements in robotics technology have expanded the applications of minimally invasive techniques across various specialties, including urology, gynecology, and orthopedics. Additionally, there is a growing focus on single-port and natural orifice surgery, aiming to further minimize incisions and trauma to the patient's body. These approaches promise reduced post-operative pain, faster recovery, and better cosmetic outcomes.
Key Players:
Medtronic plc
Johnson & Johnson (Ethicon, Inc.)
Stryker Corporation
Intuitive Surgical, Inc.
Boston Scientific Corporation
B. Braun Melsungen AG
Olympus Corporation
Smith & Nephew plc
Abbott Laboratories
Karl Storz GmbH & Co. KG
Zimmer Biomet Holdings, Inc.
Applied Medical Resources Corporation
Chapter 1. Minimally Invasive Surgery (MIS) Market – Scope & Methodology
1.1 Market Segmentation
1.2 Scope, Assumptions & Limitations
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Minimally Invasive Surgery (MIS) Market – Executive Summary
2.1 Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis
Chapter 3. Minimally Invasive Surgery (MIS) Market – Competition Scenario
3.1 Market Share Analysis & Company Benchmarking
3.2 Competitive Strategy & Development Scenario
3.3 Competitive Pricing Analysis
3.4 Supplier-Distributor Analysis
Chapter 4. Minimally Invasive Surgery (MIS) Market Entry Scenario
4.1 Regulatory Scenario
4.2 Case Studies – Key Start-ups
4.3 Customer Analysis
4.4 PESTLE Analysis
4.5 Porters Five Force Model
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Powers of Customers
4.5.3 Threat of New Entrants
4.5.4 Rivalry among Existing Players
4.5.5 Threat of Substitutes
Chapter 5. Minimally Invasive Surgery (MIS) Market – Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Minimally Invasive Surgery (MIS) Market – By Type of Surgery
6.1 Introduction/Key Findings
6.2 Laparoscopic Surgery
6.3 Endoscopic Surgery
6.4 Robotic Surgery
6.5 Others
6.6 Y-O-Y Growth trend Analysis By Type of Surgery
6.7 Absolute $ Opportunity Analysis By Type of Surgery, 2024-2030
Chapter 7. Minimally Invasive Surgery (MIS) Market – By Device Type
7.1 Introduction/Key Findings
7.2 Handheld Instruments
7.3 Electrosurgical Instruments
7.4 Guiding Devices
7.5 Inflation Systems
7.6 Others
7.7 Y-O-Y Growth trend Analysis By Device Type
7.8 Absolute $ Opportunity Analysis By Device Type, 2024-2030
Chapter 8. Minimally Invasive Surgery (MIS) Market – By End-User
8.1 Introduction/Key Findings
8.2 Hospitals
8.3 Ambulatory Surgical Centers (ASCs)
8.4 Clinics
8.5 Specialty Clinics
8.6 Others
8.7 Y-O-Y Growth trend Analysis By End-User
8.8 Absolute $ Opportunity Analysis By End-User, 2024-2030
Chapter 9. Minimally Invasive Surgery (MIS) Market , By Geography – Market Size, Forecast, Trends & Insights
9.1 North America
9.1.1 By Country
9.1.1.1 U.S.A.
9.1.1.2 Canada
9.1.1.3 Mexico
9.1.2 By Type of Surgery
9.1.3 By Device Type
9.1.4 By By End-User
9.1.5 Countries & Segments - Market Attractiveness Analysis
9.2 Europe
9.2.1 By Country
9.2.1.1 U.K
9.2.1.2 Germany
9.2.1.3 France
9.2.1.4 Italy
9.2.1.5 Spain
9.2.1.6 Rest of Europe
9.2.2 By Type of Surgery
9.2.3 By Device Type
9.2.4 By End-User
9.2.5 Countries & Segments - Market Attractiveness Analysis
9.3 Asia Pacific
9.3.1 By Country
9.3.1.1 China
9.3.1.2 Japan
9.3.1.3 South Korea
9.3.1.4 India
9.3.1.5 Australia & New Zealand
9.3.1.6 Rest of Asia-Pacific
9.3.2 By Type of Surgery
9.3.3 By Device Type
9.3.4 By End-User
9.3.5 Countries & Segments - Market Attractiveness Analysis
9.4 South America
9.4.1 By Country
9.4.1.1 Brazil
9.4.1.2 Argentina
9.4.1.3 Colombia
9.4.1.4 Chile
9.4.1.5 Rest of South America
9.4.2 By Type of Surgery
9.4.3 By Device Type
9.4.4 By End-User
9.4.5 Countries & Segments - Market Attractiveness Analysis
9.5 Middle East & Africa
9.5.1 By Country
9.5.1.1 United Arab Emirates (UAE)
9.5.1.2 Saudi Arabia
9.5.1.3 Qatar
9.5.1.4 Israel
9.5.1.5 South Africa
9.5.1.6 Nigeria
9.5.1.7 Kenya
9.5.1.8 Egypt
9.5.1.9 Rest of MEA
9.5.2 By Type of Surgery
9.5.3 By Device Type
9.5.4 By End-User
9.5.5 Countries & Segments - Market Attractiveness Analysis
Chapter 10. Minimally Invasive Surgery (MIS) Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
10.1 Medtronic plc
10.2 Johnson & Johnson (Ethicon, Inc.)
10.3 Stryker Corporation
10.4 Intuitive Surgical, Inc.
10.5 Boston Scientific Corporation
10.6 B. Braun Melsungen AG
10.7 Olympus Corporation
10.8 Smith & Nephew plc
10.9 Abbott Laboratories
10.10 Karl Storz GmbH & Co. KG
10.11 Zimmer Biomet Holdings, Inc.
10.12 Applied Medical Resources Corporation
2500
4250
5250
6900
Frequently Asked Questions
The market for minimally invasive surgery (MIS) was estimated to be worth USD 60 billion in 2023 and is expected to increase to USD 116.92 billion by 2030, with a projected compound annual growth rate (CAGR) of 10% from 2024 to 2030.
The primary drivers of the global minimally invasive surgery (MIS) market include the increasing prevalence of chronic diseases, advancements in surgical technologies, and growing demand for shorter hospital stays and quicker recovery times.
The key challenges facing the global minimally invasive surgery (MIS) market include the high cost of equipment, limited access to advanced technology in certain regions, and the learning curve associated with adopting new surgical techniques.
In 2023, North America held the largest share of the global minimally invasive surgery (MIS) market.
Medtronic plc, Johnson & Johnson (Ethicon, Inc.), Stryker Corporation, Intuitive Surgical, Inc., Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Smith & Nephew plc, Abbott Laboratories, Karl Storz GmbH & Co. KG, Zimmer Biomet Holdings, Inc., and Applied Medical Resources Corporation are the main players.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.